Moderate-to-severe disability affects nearly one-third of patients with inflammatory bowel disease, according to a recent review.

Buying or selling wild animals, whether for food, pets or other uses, may increase the risk of diseases spreading to people.

After months of leadership changes, President Donald Trump has chosen a new candidate to lead the CDC, Dr Erica Schwartz.

The FDA has granted Fast Track designation to pevifoscorvir sodium, an oral capsid assembly modulator for chronic HBV.

Tennessee hospitalizations for injection drug use-related infections remain a major clinical and economic burden despite rates plateauing after 2018.

Ceftolozane-tazobactam shows a higher clinical cure rate than ceftazidime-avibactam for MDR/DTR P aeruginosa infections.

Blaine Labs recalls Revitaderm and Tridergel wound care gels due to microbial contamination with Lysinibacillus fusiformis.

A 10-year follow-up confirms the potential role of doxycycline in treating conjunctival lymphoma associated with urogenital chlamydia.

Mortality rates for DTR Gram-negative infections remain unchanged despite the increased availability and use of newer antimicrobial agents.

The US Environmental Protection Agency has paused decisions on uses for dozens of "forever chemicals," also known as PFAS.

About 1 in 4 US adults report using artificial intelligence tools or chatbots for physical or mental health information.

Nearly 12,000 people in the UK who received a first dose of the MenB vaccine will now be offered a second dose starting next week after a deadly outbreak.